The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies
Open accessAbstract
Rationale The neurotrophin hypothesis of major depressive disorder (MDD) postulates that this illness results from aberrant neurogenesis in brain regions that regulates emotion and memory. Notwithstanding this theory has primarily implicated BDNF in the neurobiology of MDD. Recent evidence suggests that other trophic factors namely GDNF, VEGF and IGF-1 may also be involved.Purpose The present review aimed to critically summarize evidence regarding changes in GDNF, IGF-1 and VEGF in individuals with MDD compared to healthy controls. In addition, we also evaluated the role of these mediators as potential treatment response biomarkers for MDD.Methods A comprehensive review of original studies studies measuring peripheral, central or mRNA levels of GDNF, IGF-1 or VEGF in patients with MDD was conducted. The PubMed/MEDLINE database was searched for peer-reviewed studies published in English through June 2nd, 2015.Results Most studies reported a reduction in peripheral GDNF and its mRNA levels in MDD patients versus controls. In contrast, IGF-1 levels in MDD patients compared to controls were discrepant across studies. Finally, most studies reported high peripheral VEGF levels and mRNA expression in MDD patients compared to healthy controls.Conclusions GDNF, IGF-1 and VEGF levels and their mRNA expression appear to be differentially altered in MDD patients compared to healthy individuals, indicating that these molecules might play an important role in the pathophysiology of depression and antidepressant action of therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It binds to the GDNF-family receptors α1 (GFRα1) activating tyrosine kinase signaling (Sharma et al. 2016).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Sharma et al. 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Decreased serum brain-derived neurotrophic factor levels in major depressed patients
Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., & Aubry, J.-M. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00005-7 · Cited by 1,232
Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164
Dwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.804 · Cited by 875
Karege, F., Vaudan, G., Schwald, M., Perroud, N., & La Harpe, R. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.12.020 · Cited by 600
Taliaz, D., Stall, N., Dar, D. E., & Zangen, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.67 · Cited by 454
Guilloux, J.-P., Douillard-Guilloux, G., Kota, R., Wang, X., Gardier, A. M., Martinowich, K., Tseng, G. C., Lewis, D. A., & Sibille, E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.113 · Cited by 378
Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects
Hoshaw, B. A., Malberg, J. E., & Lucki, I. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.007 · Cited by 348
Mobilization, E. (1989) · Cited by 298
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–142 of 142
Nguyen, T. N. B., Ely, B. A., Pick, D., Patel, M., Xie, H., Kim‐Schulze, S., & Gabbay, V. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.07.163 · Cited by 7
Wunram, H. L., Kasparbauer, A., Oberste, M., & Bender, S. (2023) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000954 · Cited by 7
Zhang, Y., Li, X., Wang, X., Wang, X., Li, G., Xue, Q.-Y., Zhang, M., & Ao, H. (2023) · Pharmaceuticals · doi:10.3390/ph16111607 · Cited by 6
Rajkumar, R., Bhaya, B., Mamilla, D., Czech, T., Kisseih, E., Saini, A., & Chouthai, N. S. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.10.001 · Cited by 6
Hisaoka‐Nakashima, K., Matsumoto, C., Azuma, H., Taki, S., Takebayashi, M., Nakata, Y., & Morioka, N. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00383 · Cited by 5
Exploring the sortilin related receptor, SorLA, in depression
Buttenschøn, H. N., Elfving, B., Nielsen, M., Skeldal, S., Ollendorff, M. K., Mors, O. N., & Glerup, S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.050 · Cited by 5
Groh, A., Jahn, K., Burkert, A., Neyazi, A., Schares, L., Janke, E., Rehme, M., Schuster, R., Hillemacher, T., Bleich, S., et al. (2017) · European Addiction Research · doi:10.1159/000485030 · Cited by 4
Elfving, B., Liebenberg, N., du Jardin, K. G., Sánchez, C., Wegener, G., & Müller, H. K. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.10.011 · Cited by 4
Fischer, I. C., Overstreet, C. M., Cabrera‐Mendoza, B., Qiu, D., Krystal, J. H., Polimanti, R. A., Gelernter, J. E., & Pietrzak, R. H. (2025) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2025.2498352 · Cited by 3
Basic mechanisms of, and treatment targets for, depressive disorders
Pereira, M., Andreatini, R., & Svenningsson, P. (2020) · doi:10.1093/med/9780198713005.003.0074 · Cited by 3
Gomułka, K., Liebhart, J., & Mędrala, W. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225301 · Cited by 3
A lasma rotein rofile of ntidepressant esponse to omega-3 atty cids
Lindahl, J., Stiernborg, M., Ventorp, F., Suneson, K., Veibäck, G. S., Tjernberg, J., Ståhl, D., Hjärn, M., Lavebratt, C., & Lindqvist, D. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111481 · Cited by 2
Kamyshna, I. I., Pavlovych, L., & Kamyshnyi, O. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.7896 · Cited by 2
Joseph, D. T., Bajpai, M., Yadav, D. K., Sharma, S., Anand, S., & Khan, M. A. (2023) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2023.09.019 · Cited by 2
Cao, M., Fan, B.-B., Xu, L., Xu, J., & Zhang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-22692-x · Cited by 2
Neurotrophic factors in systemic lupus erythematosus: markers of disease activity
Dias, A. F. M. D. P., Lanna, C. C. D., Teixeira, A. L., & Ferreira, G. A. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/7ncg6y · Cited by 2
Zheng, G., Zhang, H., Wang, Z., Zhan, J., & Guo, H. (2016) · International Congress on Image and Signal Processing (CISP) · doi:10.1109/cisp-bmei.2016.7853019 · Cited by 1
Mood Disorders: Clinical Results
Moffa, A. H., Brunoni, A. R., & Loo, C. K. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-76136-3_21 · Cited by 1
Karabanov, S. Y., Kibitkina, A. A., Vasilevskaya, E. R., & Fedulova, L. (2024) · Genes and Cells · doi:10.17816/gc631853 · Cited by 1
Davarinejad, O., Komasi, S., Moradi, M., Nouraei, S., & Kazemisafa, F. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.09.030 · Cited by 1
Effects of vitamin D and exercise on depression: exploring the VEGF-mediated MAPK/ERK pathway
Abdelhady, E. G., Abdelaziz, G. M., Soliman, A. S., Ahmed, A. A., & Gaber, N. A. A. E. (2026) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-026-01075-7 · Cited by 1
Physical Activity as a Tool for Enhancing Learning
Rahman, A. A., Teo, W., Chua, T. B. K., & Chia, M. (2023) · Springer eBooks · doi:10.1007/978-981-99-5378-3_8 · Cited by 2
Biological Markers to Differentiate the Subtypes of Depression
Yun, J., & Lee, S. (2017) · Springer eBooks · doi:10.1007/978-981-10-6580-4_9 · Cited by 2
Craighead, W. E., Klein, D. N., Gillespie, C. F., Ritschel, L. A., & Phillips, K. E. (2017) · Psychopathology · doi:10.1002/9781394258949.ch7 · Cited by 1
Lin, E., Kuo, P.-H., Liu, Y.-L., Yang, A., & Tsai, S.-J. (2019) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_30_19
Peng, Q., Kong, Y., Shi, L., Yan, Y. C., Yao, Y., Wen, Y., Liang, Y.-M., Lai, C., Deng, Z., & Yan, H. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135361
書評 フレデリック・C・ビーザー著 ルートレッジ社、二〇〇五年 『ヘーゲル』
杉田, 孝. (2007) · ヘーゲル哲学研究
Nguyen, T. N. B., Ely, B. A., Pick, D., Patel, M., Xie, H., Kim‐Schulze, S., & Gabbay, V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.07.455522
Uchiyama, M. (2021) · Sleep and Biological Rhythms · doi:10.1007/s41105-021-00356-3
Neurotrophic Mechanisms of Depression
Duman, R. S. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0027
Peripheral biomarkers in major depressive disorders
Lazáry, J., Miezah, D., Moustafa, A. A., & Kéri, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817676-4.00001-8
Nunes, F. D. D. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2022.tde-18082022-102408
Brain RAS in CNS Diseases: Beneficial Effects of Small Molecule Agonists and Inhibitors
Wright, J. W., & Harding, J. W. (2022) · Annals of Hematology & Oncology · doi:10.26420/annhematoloncol.2022.1388
The Role of Amature Sports on Cognitive Functions
Morović, S., & Demarin, V. (2023) · Springer eBooks · doi:10.1007/978-3-031-33013-1_13
Sega, P. A. S., Indrayani, I. A. S., & Wahyuni, A. A. S. (2023) · Intisari Sains Medis · doi:10.15562/ism.v14i2.1758
Neuroprotection induced by neurotrophic factors
Réus, G. Z., Manosso, L. M., Botelho, M. E. M., Arent, C. O., Pedro, L. C., & Quevedo, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00063-4
Self-citationWang, S.-W., Mi, W., Hao, X.-N., Liu, X., Wen, X., Zhao, M., Jiang, H., Wang, W., Li, T., Tan, Z.-L., et al. (2025) · Depression and Anxiety · doi:10.1155/da/6130764 · Cited by 2
Zhu, Z., Yang, J., Dai, D., Zhang, L., Zhang, Y., Yin, X., Cai, Y., Li, H., & Tao, W. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07612-7
Gabuzda, D. H., Yin, J., Uno, H., & Morgello, S. (2026) · Viruses · doi:10.3390/v18060628
Li, G., & Li, Y. (2026) · Brain Structure and Function · doi:10.1007/s00429-026-03132-6
The course of insulin-like growth factor levels during electroconvulsive therapy
Lamadé, E. K., Karl, S., Deicher, A., Aksay, S. S., Breitfelder, G., Spangemacher, M., Kunz, D., Böttcher, K.-T., Insan, S., Witt, S. H., et al. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02411-x
Metadata
- Authors
- Sharma, A. N., da Costa e Silva, B. F. B., Soares, J. C., Carvalho, A. F., & Quevedo, J.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- ORCID
- Soares, Jair C.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 197
- Pages
- 9-20
- ISSN
- 0165-0327 (ISSN-L)
- PMC
- PMC4837031
- OpenAlex
- W2288312973
- Cited by
- 142
- References
- 74
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 9 · 2023: 10 · 2022: 11 · 2021: 16 · 2020: 18 · 2019: 17 · 2018: 21 · 2017: 17 · 2016: 5
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Affective Disorders (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R01MH085667)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- major depressive disorder, glial cell line-derived neurotrophic factor, insulin-like growth factor I, vascular endothelial growth factor, neurotrophins, neurogenesis, treatment response biomarkers, peripheral biomarkers, mRNA expression, antidepressant action, depression pathophysiology
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Female, Humans, Insulin-Like Growth Factor I, Male, Biomarkers, Vascular Endothelial Growth Factor A, Glial Cell Line-Derived Neurotrophic Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review